Is brilinta going generic?

Short answer: In the United States, there isn’t a FDA-approved generic ticagrelor (Brilinta) right now. Generic ticagrelor is available in some other countries, but it’s not universally available and status can change.

If you’re outside the US or want to check the latest status for your location, you can:
- Look up ticagrelor in the local drug regulator’s database or the country’s Orange Book equivalents.
- Ask your pharmacist or prescriber to confirm whether a generic is available where you live.

If cost is your main concern, you could discuss with your clinician about:
- Switching to a generic alternative if appropriate (for example, clopidogrel is a widely available generic antiplatelet, but it has different efficacy and safety profiles).
- Patient assistance programs or savings cards offered by the manufacturer.
- Staying on Brilinta with insurance optimization, if a switch isn’t advisable.

If you tell me your country (and whether you want the latest regulatory status or cost/options), I can tailor the guidance. Note: never change antiplatelet therapy without medical supervision, since abrupt stopping or switching can increase risk of serious cardiovascular events.